News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
GlaxoSmithKline, Merck & Co., Inc., Sanofi-Aventis (France) Rotavirus Vaccines Save Poorest Children
August 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Trials in Asia and Africa show rotavirus vaccines can save the lives of even the poorest young children and programs should begin to vaccinate as many as possible, researchers reported on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Merck & Co.
Sanofi
GSK
MORE ON THIS TOPIC
Rare diseases
Rhythm’s obesity drug scores ‘better than expected’ weight loss in rare genetic disease
June 15, 2026
·
2 min read
·
Tristan Manalac
Cancer
Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy
June 15, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH INTELLIA THERAPEUTICS
The commercial launch playbook: Team structure, readiness and execution
June 15, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Rare diseases
Amgen shores up Tavneos’ FDA defense with Duke data analysis
June 12, 2026
·
2 min read
·
Tristan Manalac